Dr. Janewit Wongboonsin

Consultant

10 Years of Experience

Nephrologist

MD, Diploma, Fellowship

English, Thai

Consultation Fee $ 19

Book an Appointment

Dr. Janewit Wongboonsin is a renowned nephrologist in Thailand.
With more than 10 years of clinical experience, he brings his proficient skills to cure patients.
He is brilliant at handling cases of:
- Glomerular disease
- Renal genetics
- Complement-mediated kidney diseases
- Genetic kidney disease
- Diabetic kidney disease
- Chronic kidney disease of unknown etiology
Regarding his educational qualifications, he completed his MD with First Class Honors from the Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand, in 2014.
Later, he earned a Diploma in Internal Medicine from the American Board of Internal Medicine in 2019.
He also pursued a specialized Diploma in Nephrology from the American Board of Nephrology in 2022.
In 2023, he completed a Fellowship in Renal Genetics at the Brigham and Women's Hospital/Boston Children's Hospital, Harvard Medical School, Boston, USA, to get more hands-on experience.
In an attempt to share his expert knowledge with fellow nephrologists, he has published several research papers in popular journals, such as the Journal of Stroke and Cerebrovascular Diseases.
Dr. Wongboonsin is a member of the American Board of Internal Medicine, one of the most honored professional organizations among doctors.

Get a Treatment Plan Within 1 Hour

Name*

Mobile Number*

Is the above number on WhatsApp? *

Yes

Query

MD, Faculty of Medicine, Siriraj Hospital, Mahidol University, Thailand, 2014
Diploma in Internal Medicine, American Board of Internal Medicine, 2019
Diploma in Nephrology, American Board of Nephrology, 2022
Fellowship in Renal Genetics, Brigham and Women's Hospital/Boston Children's Hospital, Harvard Medical School, Boston, MA, USA, 2023

Wongboonsin, J., Neves, P. D., Watanabe, A., Watanabe, E. H., Narcizo, A. M., Nunes, K., Lerario, A. M., Ferreira, F. M., Cavalcante, L. B.,Malheiros, D. M., et al. (2024). Idiopathic collapsing glomerulopathy is associated with APOL1 high-risk genotypes or Mendelian variants in most affected individuals in a highly admixed population. Kidney International, 105(3), 593–607.
Wongboonsin, J., Migdady, I., Roy, A., Duskin, J. A., McKeown, M. E., Fischer, D., Barra, M. E., Schontz, M., Bevers, M. B., Arnaout, O., Izzy, S., & Snider, S. B. (2022). Volume replacement is associated with a diminished osmolar effect of mannitol in patients with acute brain injury. Journal of Stroke and Cerebrovascular Diseases, 31(12), 106867.
Wongboonsin, J., Hundert, J., Benoit, S., et al. (2022). A Randomized Control Trial of Ravulizumab for Treatment of Patients With COVID-19 Infection and Kidney Injury. Kidney International Reports, 7(12), 2714–2717.
Wongboonsin, J., Shah, S. I., Marty, F. M., Mount, D. B., Rennke, H. G., & Murakami, N. (2021). Osmotic Tubulopathy in a Patient With COVID-19 Treated With Remdesivir. Kidney International Reports, 6(7), 1987–1991.
Wongboonsin, J., Merighi, J. R., Walker, P. F., & Drawz, P. E. (2020). Travel arrangements in chronic hemodialysis patients: A qualitative study. Hemodialysis International, 25(1), 113–122.